Clinical Trial Update: "JACTAX" Trial Drug Eluting Stent Trial [NA]

View source ↗

Summary

Clinical trial update shows the JACTAX drug-eluting stent trial for coronary artery disease is completed; no trial results are provided in the snippet.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• JACTAX Drug Eluting Stent

Snippet

Sponsor: Boston Scientific Corporation | Conditions: Coronary Artery Disease | NA | Status: COMPLETED